Research & Development

Sangamo's Gene Therapy Shows Promise for Fabry Disease Treatment
Research & Development Sangamo's Gene Therapy Shows Promise for Fabry Disease Treatment

Sangamo Therapeutics, Inc., a leading genomic medicine company, has reported promising updated data from the Phase 1/2 STAAR study. This study explores the efficacy of isaralgagene civaparvovec (ST-920) as a treatment for Fabry disease. The analysis, which reflects data up to September 12, 2024,

Allarity Therapeutics Expands Phase 2 Trial of Stenoparib for Ovarian Cancer
Research & Development Allarity Therapeutics Expands Phase 2 Trial of Stenoparib for Ovarian Cancer

Allarity Therapeutics, Inc. has announced the expansion of their Phase 2 clinical trial for stenoparib, a dual PARP/Wnt pathway inhibitor, aimed at treating advanced ovarian cancer. Their recent decision seeks to accelerate the drug's clinical development and work towards FDA regulatory

Enhancing Clinical Trial Enrollment and Retention with Technology
Research & Development Enhancing Clinical Trial Enrollment and Retention with Technology

Clinical trials are fundamental to the development of new medical treatments and the advancement of healthcare. However, enrolling and retaining participants in these trials has been a persistent challenge over the years. The perceived difficulty of involvement, alongside high dropout rates, can

Unlocking the Potential of Value-Added Medicines in Modern Healthcare
Research & Development Unlocking the Potential of Value-Added Medicines in Modern Healthcare

The 21st century has seen the pharmaceutical industry face mounting challenges such as escalating competition and pricing pressures. Consequently, developers and manufacturers are pioneering innovative strategies to differentiate their products and instill value, particularly in the saturated

Proteo-Genomics Study Reveals New Insights Into Gut Microbiome and Health
Research & Development Proteo-Genomics Study Reveals New Insights Into Gut Microbiome and Health

The human gut microbiome plays a crucial role in overall health, influencing everything from digestion to immune function. Recent advancements in proteo-genomics have provided unprecedented insights into the complex interactions within the gut microbiome. A groundbreaking study has utilized

Can Psychedelics Revolutionize Treatment for Resistant Depression?
Research & Development Can Psychedelics Revolutionize Treatment for Resistant Depression?

In a groundbreaking development, the recent trials of a drug developed by Ireland-based psychedelics biotech company GH Research have showcased its potential in treating treatment-resistant depression. The mid-stage clinical trial, comprising 81 participants, revealed a significant reduction in

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later